Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in Children with Allergic Asthma
NCT00079937Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2004
- Primary completion
- Mar 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of omalizumab in allergic asthma, sponsored by Novartis. Started Apr 2004; status: completed.
02
Drugs
omalizumab
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT00079937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079937.